Author:
Madani Tonekaboni Seyed Ali,Beri Gangesh,Haibe-Kains Benjamin
Subject
Genetics(clinical),Genetics,Molecular Medicine
Reference30 articles.
1. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.;Baselga;Lancet,2012
2. Response to neoadjuvant trastuzumab and chemotherapy in ER and ER- HER2-positive breast cancers: gene expression analysis.;Bianchini;J. Clin. Oncol.,2011
3. CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells.;Boulbes;Breast Cancer Res. Treat.,2015
4. Erratum: Near-optimal probabilistic RNA-seq quantification.;Bray;Nat. Biotechnol.,2016
5. Race, breast cancer subtypes, and survival in the carolina breast cancer study.;Carey;JAMA,2006
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献